Serplulimab+Regorafenib +Hepatic Artery Bicarbonate Infusion in Patients With Colorectal Cancer and Liver Metastases

NCT05894837 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer
Liver Metastases

Interventions

DRUG: Serplulimab+Regorafenib
DRUG: Hepatic Artery Bicarbonate Infusion

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University